REGENXBIO Inc. Other Current Assets
REGENXBIO Inc. (RGNX) had Other Current Assets of $11.76 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Current $11.76M.
- 2026-03-31: Other Assets, Current $14.44M.
- 2025-12-31: Other Assets, Current $12.90M.
- 2025-09-30: Other Assets, Current $19.47M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.76M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $14.44M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $12.90M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $19.47M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $19.48M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $16.08M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $13.77M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $16.08M 10-Q · filed 2025-05-12 | $23.33M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $23.50M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $27.30M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $20.40M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $23.35M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $22.23M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $23.00M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $9.35M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $6.85M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $8.72M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $7.18M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $10.20M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $5.89M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $5.16M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $2.88M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $1.95M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $7.20M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $7.27M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $7.03M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $4.20M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $2.41M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.28M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $4.00M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $3.83M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $4.83M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.35M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.21M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.41M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $1.39M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.25M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $922.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $1.01M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $2.00M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.44M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $851.00K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $127.00K 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |